Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3109-2026

Halyard IV Start Kit Non-Sterile REF: KRIV26-02 Recall

Halyard IV Start Kit Non-Sterile REF: KRIV26-02

FDA recall Class II

Ongoing

FDA lists this Class II recall for Halyard IV Start Kit Non-Sterile REF: KRIV26-02. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3109-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 14, 2026
FDA report date
Sep 16, 2026
Quantity in commerce
98 Kits
Distribution
See key details
FDA cause
Packaging process control

What is being recalled?

Halyard IV Start Kit Non-Sterile REF: KRIV26-02

Affected model & UDI checker

Search the exact identifiers published for Z-3109-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
KRIV26-02Halyard IV Start Kit Non-Sterile REF: KRIV26-02Check source noticeNot specified
Not specifiedHalyard IV Start Kit Non-Sterile REF: KRIV26-02Check source notice10809160460481
FDA code information

Lot Number:1658438 7/31/2026 UDI: 10809160460481

View the original FDA recall notice

Why was this product recalled?

Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which lacks sterility assurance due to to wrinkles in the paper lidding which may breach the seal area.

What actions did AVID Medical, Inc. take?

On July 14, 2026, Avid Medical Inc. a subsidiary of Owens Minor issued an Urgent Medical Device Recall to affected consignees via email. I Avid Medical Inc. requested consignees to take the following actions: 1. Identify, segregate, and quarantine all impacted product identified. 1a. Discontinue use of the BD ChloraPrep" Clear - 1 mL and FREPP" Clear 1.5 mL Applicators. 1b. Add warning labels to affected AVID kits to ensure all users are aware of the actions to discard the impacted component prior to use. A labeling template is enclosed for printing labels which can be affixed on all affected kits and cases in inventory. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling. 2. Customers (end-users): If you received product from a distributor, please contact the distributor or your sales representative with any questions you may have. 3. Distributors: If any of the affected kits identified above were further distributed, please ensure all end-users are appropriately notified and maintain records of effectiveness. 4. Complete the attached Recall Response Form and return by July 31, 2026.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology